Lenalidomide is an oral immunomodulatory drug widely used in the treatment of multiple myeloma, myelodysplastic syndromes (MDS), and certain types of lymphoma. It works by enhancing the immune system, inhibiting cancer cell growth, and reducing the formation of abnormal blood vessels that support tumor growth. Lenalidomide has significantly improved survival rates and quality of life for patients with these conditions.

This medication is typically prescribed in combination with other therapies such as dexamethasone or chemotherapy for better treatment outcomes. While effective, it may cause side effects such as fatigue, low blood cell counts, and an increased risk of blood clots, requiring close medical supervision during treatment.

Several pharmaceutical companies serve as leading Lenalidomide manufacturers, ensuring a steady supply of high-quality formulations for patients worldwide. These manufacturers adhere to strict regulatory standards to ensure the safety, efficacy, and affordability of lenalidomide. With the growing demand for effective cancer treatments, reliable Lenalidomide manufacturers play a crucial role in making this life-saving drug accessible to healthcare providers and patients globally.